• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[智利囊性纤维化儿童、青少年和成人生活质量评估工具的内容效度验证:西班牙语版智利修订版囊性纤维化问卷(CFQ-R)]

[Content validation for the Chilean population of the quality of life assessment instrument in children, adolescents and adults with Cystic Fibrosis: CFQ-R CYSTIC FIBROSIS QUESTIONNAIRE-REVISED version in Spanish, Chile].

作者信息

Navarro T Sandra, Boza C María L, Molina M Yerko, Lezana S Viviana, Melo T Joel, Jakubson S Leticia, Hernández C Jury, Barrientos I Hortensia, Zenteno A Daniel, Contreras E Ilse

机构信息

Pontificia Universidad Católica de Chile, Santiago, Chile.

Universidad de Chile, Santiago, Chile.

出版信息

Andes Pediatr. 2022 Jun;93(3):312-326. doi: 10.32641/andespediatr.v93i3.3871.

DOI:10.32641/andespediatr.v93i3.3871
PMID:35857002
Abstract

INTRODUCTION

Cystic Fibrosis (CF) is the most frequent chronic hereditary disease in the white race. Although the impact on the quality of life of this disease is significant, there are no validated instruments in the Chilean population to measure it.

OBJECTIVE

To carry out a cultural and linguistic adaptation and validate the content and reliability of the CFQ-R Cystic Fibrosis Questionnaire, Spanish version 2.0.

PATIENTS AND METHOD

The process was carried out in two stages. The first stage consists of an ins trumental design to adapt it culturally and linguistically, evaluate content validity by consulting ex perts, and test the comprehension of the questionnaire in patients and parents through qualitative interviews and a focus group. In the second stage with an observational and cross-sectional design in a sample of 122 people with CF or their caregivers, the behavior of the questionnaire was analyzed using descriptive statistics and Cronbach's alpha for reliability.

RESULTS

Stage 1: the instrument in its three versions is considered valid with Lynn's index > 0.8 and Validity Coefficient > 0.7. Stage 2: The adolescent/adult and parent/caregiver versions obtain Cronbach's a > 0.7 and an average > 3 in most dimensions.

CONCLUSION

The questionnaire is adapted and validated in the Chilean population and requires minor modifications. This version is reliable, valid, and allows the assessment of the quality of life in people with CF. It is suggested to increase the sample for the analysis of construct validity with a larger number of patients.

摘要

引言

囊性纤维化(CF)是白种人中最常见的慢性遗传性疾病。尽管这种疾病对生活质量的影响很大,但智利人群中尚无经过验证的测量工具。

目的

进行文化和语言适应性调整,并验证CFQ-R囊性纤维化问卷西班牙语2.0版本的内容和可靠性。

患者与方法

该过程分两个阶段进行。第一阶段包括进行工具设计以使其在文化和语言上得以适应,通过咨询专家评估内容效度,并通过定性访谈和焦点小组测试患者及家长对问卷的理解。在第二阶段,采用观察性横断面设计,对122名囊性纤维化患者或其照护者进行抽样,使用描述性统计和克朗巴哈系数(Cronbach's alpha)分析问卷的可靠性。

结果

第一阶段:该工具的三个版本在林恩指数(Lynn's index)> 0.8且效度系数> 0.7时被认为有效。第二阶段:青少年/成人版和家长/照护者版在大多数维度上克朗巴哈系数α> 0.7且平均分> 3。

结论

该问卷已在智利人群中进行了适应性调整和验证,只需进行微小修改。这个版本可靠、有效,能够对囊性纤维化患者的生活质量进行评估。建议增加样本量,以便对更多患者进行结构效度分析。

相似文献

1
[Content validation for the Chilean population of the quality of life assessment instrument in children, adolescents and adults with Cystic Fibrosis: CFQ-R CYSTIC FIBROSIS QUESTIONNAIRE-REVISED version in Spanish, Chile].[智利囊性纤维化儿童、青少年和成人生活质量评估工具的内容效度验证:西班牙语版智利修订版囊性纤维化问卷(CFQ-R)]
Andes Pediatr. 2022 Jun;93(3):312-326. doi: 10.32641/andespediatr.v93i3.3871.
2
Spanish adaptation and validation of the child- and parent-report cystic fibrosis questionnaire-revised (CFQ-R).西班牙语版儿童和家长报告囊性纤维化问卷修订版(CFQ-R)的适应和验证。
Pediatr Pulmonol. 2023 Dec;58(12):3447-3457. doi: 10.1002/ppul.26671. Epub 2023 Sep 13.
3
Cross-cultural adaptation and validation in spanish of the malocclusion impact questionnaire (MIQ).错颌畸形影响问卷(MIQ)的西班牙语跨文化调适与验证。
Health Qual Life Outcomes. 2020 May 19;18(1):146. doi: 10.1186/s12955-020-01385-1.
4
Validity of a Spanish Version of the Leicester Cough Questionnaire in Children With Cystic Fibrosis.莱斯特咳嗽问卷西班牙语版本在囊性纤维化儿童中的有效性。
Arch Bronconeumol. 2016 Feb;52(2):63-9. doi: 10.1016/j.arbres.2015.01.016. Epub 2015 Jul 9.
5
Development and electronic validation of the revised Cystic Fibrosis Questionnaire (CFQ-R Teen/Adult): New tool for monitoring psychosocial health in CF.修订后的囊性纤维化问卷 (CFQ-R Teen/Adult) 的开发和电子验证:监测 CF 患者心理健康的新工具。
J Cyst Fibros. 2018 Sep;17(5):672-679. doi: 10.1016/j.jcf.2017.10.015. Epub 2017 Nov 20.
6
Health-related quality of life in children with cystic fibrosis: validation of the German CFQ-R.儿童囊性纤维化患者的健康相关生活质量:德国 CFQ-R 的验证。
Health Qual Life Outcomes. 2009 Dec 2;7:97. doi: 10.1186/1477-7525-7-97.
7
Reliability and validity of the Cystic Fibrosis Questionnaire-Revised for children and parents in Turkey: cross-sectional study.土耳其儿童和家长使用囊性纤维化问卷修订版的可靠性和有效性:横断面研究。
Qual Life Res. 2013 Mar;22(2):409-14. doi: 10.1007/s11136-012-0152-4. Epub 2012 Apr 11.
8
Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis.美国囊性纤维化问卷的编制与验证:一项针对囊性纤维化的健康相关生活质量测量工具
Chest. 2005 Oct;128(4):2347-54. doi: 10.1378/chest.128.4.2347.
9
Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients.用于评估儿童和成年患者生活质量的囊性纤维化问卷(CFQ)的研制。
Qual Life Res. 2003 Feb;12(1):63-76. doi: 10.1023/a:1022037320039.
10
Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis.囊性纤维化患儿健康相关生活质量疾病特异性测量方法的验证
J Pediatr Psychol. 2003 Dec;28(8):535-45. doi: 10.1093/jpepsy/jsg044.

引用本文的文献

1
Measurement properties of the Polish version of the Cystic Fibrosis Questionnaire Revised 14+ in the adult population.波兰版成人囊性纤维化问卷修订版14 +的测量属性
Sci Rep. 2025 Mar 18;15(1):9264. doi: 10.1038/s41598-025-94184-x.
2
Tools used to measure quality of life in adults with cystic fibrosis- a systematic review.用于测量成年囊性纤维化患者生活质量的工具——一项系统综述。
Health Qual Life Outcomes. 2025 Feb 4;23(1):10. doi: 10.1186/s12955-025-02338-2.